FFRangio System vs ACUSON Sequoia Select Diagnostic Ultrasound System
Similar category, different focus. These tools serve overlapping but distinct needs.
Comparability 68/100
Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
AI Verdict
The FFRangio System is a specialized AI tool for functional assessment of coronary artery disease, providing wire-free FFR guidance for PCI decisions by analyzing angiographic data. In contrast, the ACUSON Sequoia Select is a versatile AI-powered diagnostic ultrasound system focused on high-quality imaging across various specialties, including cardiology, by enhancing image acquisition and clarity. While both leverage AI in cardiology, they address different clinical needs: one for specific physiological guidance in CAD, the other for broad diagnostic imaging.
Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Frequently Asked Questions
The CathWorks FFRangio System provides wire-free and drug-free 3D FFR guidance to optimize PCI decisions for patients with coronary artery disease, eliminating the need for invasive pressure wires or hyperemic agents. The ACUSON Sequoia Select Diagnostic Ultrasound System is an advanced, AI-powered ultrasound platform for general diagnostic imaging across diverse patient populations and clinical applications, offering exceptional image quality and deeper penetration.
The FFRangio System uses AI to aid in quick angiogram analysis, transforming routine angiograms into a 3D model to provide real-time FFRangio values and insights for PCI planning. The ACUSON Sequoia Select integrates AI-powered UltraArt for automatic image parameter settings and smart automation to optimize workflow, including features like AI Abdomen for reduced sonographer hand motion and standardized measurements.
The FFRangio System provides real-time FFRangio values at every point on the coronary tree, simulated pullback curves to differentiate functional patterns of CAD, and a Lesion Impact feature to assess residual ischemia. The ACUSON Sequoia Select offers BioAcousticu2122 imaging technology for high-quality ultrasound images, InFocus Imaging for fully focused images, Virtual Touchu2122 Elastography for tissue stiffness assessment, and Contrast Enhanced Ultrasound (CEUS).
The FFRangio System is deployed on-premise and integrates seamlessly with cath lab equipment, C-arm angiography systems, the cath lab boom, and PACS. The ACUSON Sequoia Select is also an on-premise physical system, designed with user-driven design and smart automation to optimize workflow across various clinical specialties.
The FFRangio System is primarily for patients with coronary artery disease, providing FFR guidance to optimize percutaneous coronary intervention (PCI) therapy decisions. The ACUSON Sequoia Select is suitable for diverse patient populations and clinical applications including fetal, abdominal, pediatric, OB/GYN, cardiac, vascular, and musculoskeletal imaging.
The FFRangio System eliminates the need for invasive pressure wires, drugs, or a guide catheter for FFR assessment, aiming to reduce additional clinical risk, time, and cost associated with invasive FFR. While the ACUSON Sequoia Select is a non-invasive ultrasound system, it offers Contrast Enhanced Ultrasound (CEUS) with extended bubble longevity for enhanced visualization and assessment of lesions.